Infectious Disease

A Wealth of Experience

We have collaborated with our clients on projects to research infectious disease, infectious disease treatment, and complications and comorbidities of infectious disease.  Our experience includes:

  • Cholera
  • H1N1
  • Hepatitis
  • Herpes
  • HIV/AIDS
  • Hospital-acquired infections
  • Human papillomavirus
  • Influenza
  • Invasive fungal infections
  • Malaria
  • Meningococcal disease
  • MRSA
  • Respiratory tract infections
  • Respiratory syncytial virus (RSV)
  • STDs
  • Vaccines

Types of Projects

We have implemented studies to help our clients develop strategies in the infectious disease market and to develop and gain market access for products to treat infectious diseases and complications arising from treatment of infectious diseases.

Recent projects have included:

Our Experts

Michele Wilson
Director, Health Economics
Stephanie Earnshaw
Vice President, Health Economics
Juliana Meyers
Director, Health Economics
Christine Poulos
Senior Research Economist
Elizabeth Andrews
Vice President, Pharmacoepidemiology and Risk Management
Whitney Krueger
Research Epidemiologist
Samantha Kurosky
Director, Health Economics
Keith Davis
Senior Director, Health Economics
Marco Boeri
Senior Research Economist
Katherine Hicks
Director, Health Economics
Jonathan Graham
Director, Health Economics
Jin Yang
Senior Associate, Market Access and Outcomes Strategy
Bintu Sherif
Director, Biostatistics
Anita Brogan
Head, Decision Analytic Modeling, US Health Economics
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Brett Hauber
Senior Economist and VP, Health Preference Assessment
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Catherine Masaquel
Senior Director, Market Access and Outcomes Strategy
Josephine Mauskopf
Vice President, Health Economics
Dee Dee Mladsi
Head, Health Economics-Strategy and Early Modeling
Will Herring
Director, Health Economics
Alejandro Arana
Senior Director, Epidemiology
Annete Njue
Director, Market Access and Outcomes Strategy
Maria Fernandez
Senior Director, Market Access and Outcomes Strategy
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Alicia Gilsenan
Senior Director, Epidemiology
Sandra Talbird
Senior Director, Health Economics

Selected Recent Infectious Disease Publications